1. Home
  2. DAKT vs INBX Comparison

DAKT vs INBX Comparison

Compare DAKT & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Daktronics Inc.

DAKT

Daktronics Inc.

HOLD

Current Price

$20.15

Market Cap

944.7M

Sector

Industrials

ML Signal

HOLD

Logo Inhibrx Inc.

INBX

Inhibrx Inc.

HOLD

Current Price

$102.31

Market Cap

999.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DAKT
INBX
Founded
1968
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
944.7M
999.7M
IPO Year
1996
2024

Fundamental Metrics

Financial Performance
Metric
DAKT
INBX
Price
$20.15
$102.31
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$150.00
AVG Volume (30 Days)
244.2K
489.3K
Earning Date
03-04-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.75
N/A
Revenue
$608,932,000.00
$1,300,000.00
Revenue This Year
$12.06
N/A
Revenue Next Year
$9.16
N/A
P/E Ratio
$26.33
N/A
Revenue Growth
6.89
550.00
52 Week Low
$13.05
$12.80
52 Week High
$28.27
$155.29

Technical Indicators

Market Signals
Indicator
DAKT
INBX
Relative Strength Index (RSI) 54.01 45.50
Support Level $18.99 $99.20
Resistance Level $20.55 $153.14
Average True Range (ATR) 0.56 13.75
MACD 0.04 -3.93
Stochastic Oscillator 64.53 8.06

Price Performance

Historical Comparison
DAKT
INBX

About DAKT Daktronics Inc.

Daktronics Inc designs and manufactures electronic scoreboards, programmable display systems, and large-screen video displays for sporting, commercial, and transportation applications. It is engaged in a full range of activities: marketing and sales, engineering and product design and development, manufacturing, technical contracting, professional services, and customer service and support. The company offers a complete line of products, from small scoreboards and electronic displays to large multimillion-dollar video display systems as well as related control, timing, and sound systems. The company has five reportable segments: Commercial, Live Events, High School Park and Recreation, Transportation, and International. The company makes the majority of its revenue from Live events.

About INBX Inhibrx Inc.

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

Share on Social Networks: